A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial

Định dạng: PDF / Số trang: 7

Nhắn tin với admin nếu không tải được